Sheaff Brock Investment Advisors LLC Has $5.11 Million Position in UnitedHealth Group Inc (NYSE:UNH)

Sheaff Brock Investment Advisors LLC grew its position in UnitedHealth Group Inc (NYSE:UNH) by 94.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,942 shares of the healthcare conglomerate’s stock after purchasing an additional 10,149 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in UnitedHealth Group were worth $5,110,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Canton Hathaway LLC acquired a new stake in UnitedHealth Group in the first quarter worth $36,000. Truvestments Capital LLC acquired a new stake in UnitedHealth Group in the first quarter worth $42,000. Coastal Capital Group Inc. acquired a new stake in UnitedHealth Group in the second quarter worth $45,000. Creative Financial Designs Inc. ADV raised its holdings in UnitedHealth Group by 89.6% in the first quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock worth $50,000 after purchasing an additional 95 shares during the period. Finally, Financial Gravity Wealth Inc. acquired a new stake in shares of UnitedHealth Group during the first quarter worth $58,000. Institutional investors own 85.65% of the company’s stock.

In related news, Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction on Tuesday, June 11th. The shares were sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the transaction, the director now owns 187,663 shares of the company’s stock, valued at $46,540,424. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of the firm’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total transaction of $3,063,720.00. Following the completion of the transaction, the director now directly owns 61,309 shares of the company’s stock, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,000 shares of company stock valued at $9,195,620. 0.82% of the stock is owned by insiders.

UNH has been the topic of a number of research analyst reports. ValuEngine lowered shares of UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, April 18th. Cantor Fitzgerald set a $310.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Friday, July 19th. UBS Group initiated coverage on shares of UnitedHealth Group in a report on Tuesday, April 23rd. They set a “neutral” rating and a $238.00 price objective on the stock. Citigroup upgraded shares of UnitedHealth Group from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $247.00 to $280.00 in a report on Friday, May 10th. Finally, Oppenheimer set a $312.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Friday, July 19th. One analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $295.06.

UnitedHealth Group stock traded up $6.22 during mid-day trading on Tuesday, reaching $249.42. The company’s stock had a trading volume of 167,033 shares, compared to its average volume of 3,510,335. The stock has a market cap of $235.62 billion, a P/E ratio of 19.38, a price-to-earnings-growth ratio of 1.33 and a beta of 0.61. UnitedHealth Group Inc has a 12 month low of $208.07 and a 12 month high of $287.94. The firm’s 50 day simple moving average is $251.38. The company has a debt-to-equity ratio of 0.62, a current ratio of 0.67 and a quick ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating analysts’ consensus estimates of $3.46 by $0.14. The business had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a net margin of 5.51% and a return on equity of 25.20%. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter last year, the firm earned $3.14 earnings per share. As a group, analysts predict that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Bar Chart

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.